JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Coca-Cola Consolidated
COKE
$12.8B
| $2.36M | ﹤0.01% |
109,660
+70,280
| +178% | +$1.53M |
2016 Q4
4 quarters
|
|
3077
iShares US Healthcare ETF
IYH
$3.82B
| $2.36M | ﹤0.01% |
67,725
-1,085
| -2% | -$37.7K |
2013 Q2
18 quarters
|
|
3078
CALL
United Parcel Service
UPS
$79.8B
| $2.36M | ﹤0.01% |
19,800
| – | – |
2016 Q3
5 quarters
|
|
3079
First Trust Enhanced Short Maturity ETF
FTSM
$6.6B
| $2.36M | ﹤0.01% |
39,273
+1,205
| +3% | +$72.3K |
2016 Q4
4 quarters
|
|
3080
CALL
Boston Scientific
BSX
$62.1B
| $2.35M | ﹤0.01% |
+95,000
| New | +$2.62M |
2017 Q4
0 quarters
|
|
|
3081
PUT
Boston Scientific
BSX
$62.1B
| $2.35M | ﹤0.01% |
+95,000
| New | +$2.62M |
2017 Q4
0 quarters
|
|
3082
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.5B
| $2.35M | ﹤0.01% |
61,495
-1,835
| -3% | -$68.3K |
2016 Q4
4 quarters
|
|
3083
Sterling Infrastructure
STRL
$16.3B
| $2.34M | ﹤0.01% |
143,975
-58,172
| -29% | -$958K |
2017 Q2
2 quarters
|
|
|
FMSA
3084
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $2.34M | ﹤0.01% |
447,409
-534,100
| -54% | -$2.52M |
2014 Q4
12 quarters
|
|
3085
Alamo Group
ALG
$1.91B
| $2.34M | ﹤0.01% |
20,694
+3,805
| +23% | +$425K |
2016 Q1
7 quarters
|
|
3086
WSFS Financial
WSFS
$3.96B
| $2.33M | ﹤0.01% |
48,756
+4,721
| +11% | +$233K |
2013 Q2
18 quarters
|
|
3087
CALL
Deutsche Bank
DB
$65.5B
| $2.33M | ﹤0.01% |
+122,300
| New | +$2.21M |
2017 Q4
0 quarters
|
|
|
ETFC
3088
PUT
DELISTED
E*Trade Financial Corporation
ETFC
| $2.33M | ﹤0.01% |
+46,900
| New | +$2.15M |
2017 Q4
0 quarters
|
|
3089
PUT
Expedia Group
EXPE
$31.8B
| $2.32M | ﹤0.01% |
19,400
-312,000
| -94% | -$40.5M |
2017 Q2
2 quarters
|
|
|
RARX
3090
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.32M | ﹤0.01% |
273,377
+17,077
| +7% | +$210K |
2016 Q4
4 quarters
|
|
|
AVB
3091
PUT
DELISTED
AvalonBay Communities
AVB
| $2.32M | ﹤0.01% |
+13,000
| New | +$2.36M |
2017 Q4
0 quarters
|
|
3092
Townsquare Media
TSQ
$81.7M
| $2.32M | ﹤0.01% |
301,687
+202,787
| +205% | +$1.78M |
2016 Q4
4 quarters
|
|
3093
Black Hills Corp
BKH
$5.43B
| $2.31M | ﹤0.01% |
38,505
+34,417
| +842% | +$2.13M |
2013 Q2
18 quarters
|
|
|
OPTU
3094
Optimum Communications Inc
OPTU
$364M
| $2.31M | ﹤0.01% |
108,846
+33,229
| +44% | +$736K |
2017 Q2
2 quarters
|
|
3095
Fidelity Total Bond ETF
FBND
$27.9B
| $2.31M | ﹤0.01% |
45,974
+5,084
| +12% | +$256K |
2015 Q3
9 quarters
|
|
3096
Scansource
SCSC
$1.25B
| $2.31M | ﹤0.01% |
64,433
+14,274
| +28% | +$557K |
2015 Q4
8 quarters
|
|
3097
Mercury Insurance
MCY
$5.66B
| $2.3M | ﹤0.01% |
42,972
+41,783
| +3,514% | +$2.3M |
2015 Q2
10 quarters
|
|
3098
Tidewater
TDW
$4.1B
| $2.29M | ﹤0.01% |
94,026
+18,531
| +25% | +$485K |
2013 Q2
18 quarters
|
|
3099
Vanguard Extended Market ETF
VXF
$30.6B
| $2.29M | ﹤0.01% |
20,527
+5,885
| +40% | +$644K |
2013 Q2
18 quarters
|
|
|
LBY
3100
DELISTED
Libbey, Inc.
LBY
| $2.29M | ﹤0.01% |
304,744
-28,294
| -8% | -$221K |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.